Dr Aernout van Haarst | Director, European Corporate Development
Celerion

As Director, European Corporate Development, Dr. Aernout van Haarst plays a key role in supporting the growth of new services at Celerion. By leveraging his scientific and drug development expertise, Dr. Van Haarst is focused on identifying and building partnerships with specialist early phase organizations in Europe to meet our clients’ evolving needs.
 
Dr. van Haarst has over 20 years of drug development experience at CROs as well as biotechnology companies. This experience includes designing drug development strategies as well as hands-on experience in the design and conduct of early clinical studies in a breadth of therapeutic areas, and all clinical operational management including regulatory authority meetings. He led the set-up of a Phase I clinical research unit from inception in Spain, and assumed all management responsibilities including operational, regulatory compliance, financial and business development. Dr. van Haarst has a unique blend of entrepreneurial business skills balanced with a strong scientific and operational background.
 
Dr. van Haarst earned his doctorate in pharmacology from the School of Medicine at Leiden University (Netherlands) and also qualified as clinical pharmacologist in Leiden. He has a doctoral degree in Medical Biology, from the School of Medicine at the University of Utrecht (Netherlands).